Quick10K

⚲

SPDR Gold Trust

Filings

10-Q	2020-12-31	Filed 2021-02-05
10-K	2020-09-30	Filed 2020-11-24
10-Q	2020-06-30	Filed 2020-08-10
10-Q	2020-03-31	Filed 2020-05-08
10-Q	2019-12-31	Filed 2020-02-07
10-K	2019-09-30	Filed 2019-11-25
10-Q	2019-06-30	Filed 2019-08-06
10-Q	2019-03-31	Filed 2019-05-07
10-Q	2018-12-31	Filed 2019-02-08
10-K	2018-09-30	Filed 2018-11-27
10-Q	2018-06-30	Filed 2018-08-07
10-Q	2018-03-31	Filed 2018-05-02
10-Q	2017-12-31	Filed 2018-02-06
10-K	2017-09-30	Filed 2017-11-28
10-Q	2017-06-30	Filed 2017-08-04
10-Q	2017-03-31	Filed 2017-04-28
10-Q	2016-12-31	Filed 2017-01-27
10-K	2016-09-30	Filed 2016-11-28
10-Q	2016-06-30	Filed 2016-08-02
10-Q	2016-03-31	Filed 2016-04-29
10-Q	2015-12-31	Filed 2016-01-29
10-K	2015-09-30	Filed 2015-11-24
10-Q	2015-06-30	Filed 2015-07-31
10-Q	2015-03-31	Filed 2015-05-06
10-Q	2014-12-31	Filed 2015-02-06
10-K	2014-09-30	Filed 2014-11-25
10-Q	2014-06-30	Filed 2014-08-08
10-Q	2014-03-31	Filed 2014-05-09
10-Q	2013-12-31	Filed 2014-02-07
10-K	2013-09-30	Filed 2013-11-26
10-Q	2013-06-30	Filed 2013-08-08
10-Q	2013-03-31	Filed 2013-05-08
10-Q	2012-12-31	Filed 2013-02-05
10-K	2012-09-30	Filed 2012-11-28
10-Q	2012-06-30	Filed 2012-08-06
10-Q	2012-03-31	Filed 2012-05-08
10-K	2011-09-30	Filed 2011-11-22
10-Q	2011-06-30	Filed 2011-08-05
10-Q	2011-03-31	Filed 2011-05-06
10-Q	2010-12-31	Filed 2011-02-04
10-K	2010-09-30	Filed 2010-11-22
10-Q	2010-06-30	Filed 2010-08-05
10-Q	2010-03-31	Filed 2010-05-10
10-Q	2009-12-31	Filed 2010-02-05

Reports

8-K	2020-09-29
8-K	2019-02-25
8-K	2018-02-28

SPDR Gold Trust Financials

GLD Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546	323	0	0	0	0	-854
1 800 Flowers Com (FLWS)	944	42%	13.3	6%	665	336	1,266	534	37	75	1,001
10x Genomics (TXG)	4,805	75%	-490.3	-2%	573	151	61	46	-10	-9	4,357
12 Retech (RETC)	0	32%	-0.1	-1,385%	1	20	1	0	-15	-15	1
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	34	0%	0.4	-5%	164	108	18	0	-8	-8	-3
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	19	23	27	7	-3	-1	3
1895 Bancorp of Wisconsin (BCOW)	46,153		12,508.1	-0%	441	383	0	0	-0	4	46,142
1st Constitution Bancorp (FCCY)	165	0%	4.4	1%	1,343	1,204	0	0	14	33	144
1st Franklin Financial (FFC)	4		-0.6	7%	905	645	0	0	62	80	-46
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200		7.9	1%	6,691	5,858	0	0	70	136	1,073
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	2	0	0	-2	-2	0
21Vianet Group (VNET)	6,005			0%	11,151	5,788	0	0	0	0	3,344
22nd Century (XXII)	302	1%	-14.1	-36%	62	7	26	0	-22	-21	302
1Life Healthcare (ONEM)


Balance Sheet ($MM)	2009-12-31	2010-03-31	2010-06-30	2010-09-30	2010-12-31	2011-03-31	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accounts Receivable
Inventory
PP&E
Assets	30,111	30,289	37,721	37,991	38,368	36,729	37,786	42,737	44,526	46,664	47,010	50,726	52,436	47,757	37,155	35,813	31,067	32,337	31,345	30,251	27,464	28,135	26,852	24,621	21,979	32,832	40,343	40,357	30,683	33,360	34,096	35,669	34,910	36,013	33,034	28,332	32,457	32,663	36,143	44,169
Accounts Payable	0	0	1	2	2	1	2	4	1	2	2	4	1	2	2	2	1	0	0	0	4	2	2	0	0	0	0	0
Long-Term Debt
Liabilities	15	16	20	95	336	49	66	547	25	29	133	629	29	27	18	169	244	177	14	154	140	12	78	9	48	259	12	64	55	59	59	12	12	12	118	9	10	11	184	210
Stockholders' Equity


Income Statement ($MM)	2009-12-31	2010-03-31	2010-06-30	2010-09-30	2010-12-31	2011-03-31	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue
Cost of Revenue
Gross Profit	10	10	12	14	19	17	21	26	26	27	21	20	23	17	10	3	1	2	2	2
R&D
SG&A	15	15	17	19	21	24	22	26	26	30	25	26	28	28	18	15	13	12	12	12	11	10	11	2	0	0	0	0
Tax
Net Income	216	286	19	687	1,122	2,742	1,156	3,423	785	261	550	810	539	1,946	959	1,062	-502	663	68	-460	-470	-485	-375	-1,356	-1,143	3,797	2,322	-24	-4,921	2,213	-134	948	320	707	-2,020	-1,626	2,282	345	2,745	1,878


Cash Flow ($MM)	2009-12-31	2010-03-31	2010-06-30	2010-09-30	2010-12-31	2011-03-31	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash Investing
Cash Financing